Understanding how to inhibit protein interactions in lung cancer treatment
Molecular mechanism of EGFRs protein-protein interaction inhibition by a grafted peptide in NSCLC
This study is looking at how certain proteins help non-small-cell lung cancer grow and is working on creating new treatments that could stop these proteins from working together, which might help patients who have trouble with current therapies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Louisiana State Univ A&m Col Baton Rouge NIH-funded |
| Lab location | 1 site (Baton Rouge, United States) |
| Project ID | NIH-11052643 on NIH RePORTER |
What this research studies
This research focuses on the role of protein interactions in the development of non-small-cell lung cancer (NSCLC) and aims to create new peptides that can inhibit these interactions. By targeting the extracellular domains of epidermal growth factor receptors (EGFRs), the study seeks to overcome resistance to existing therapies that many NSCLC patients face. The approach involves designing sunflower trypsin inhibitor-grafted peptides that could potentially improve treatment outcomes for patients with this type of cancer. The research is particularly relevant given the high prevalence of NSCLC and the limited progress in improving survival rates over the past decade.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with non-small-cell lung cancer, particularly those who have shown resistance to current therapies.
Not a fit: Patients with other types of lung cancer or those who do not have non-small-cell lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for non-small-cell lung cancer, potentially improving survival rates and quality of life for patients.
How similar studies have performed: While the approach of targeting EGFR dimerization is promising, it is still being explored and has not yet been widely tested in clinical settings.
Where this research is happening
Baton Rouge, United States
- Louisiana State Univ A&m Col Baton Rouge — Baton Rouge, United States (Active)
Researchers
- Principal investigator: Jois, Seetharama D — Louisiana State Univ A&m Col Baton Rouge
- Study coordinator: Jois, Seetharama D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.